Materialise, a 3D printing pioneer and leader in personalized medical solutions, accelerates the delivery of patient-specific medical implants to patients in the United States with the opening of a new 3D printing facility. Surgeons increasingly embrace 3D printing solutions as they recognize the added value it brings to personalized patient care, including more predictable and accurate surgical outcomes and time savings during surgery.
At the new facility in Plymouth, Michigan, Materialise specializes in the 3D printing of personalized titanium cranio-maxillofacial (CMF) implants. CMF implants are used for facial reconstructive surgery. Until now, Materialise manufactured titanium CMF implants solely at its 3D printing facility in Belgium. With a dedicated metal 3D printing facility in the US, the company can respond to surgeons’ needs with greater reliability while significantly reducing the delivery time of fully personalized implants to hospitals across the United States. This expansion of capabilities complements Materialise’s existing production of 3D-printed surgical guides and anatomical models in the United States.
Materialise has more than three decades of experience in developing medical solutions and offers a comprehensive range of 3D-printed guides and implants. The company produces 280,000 personalized 3D-printed instruments and implants per year, including 160,000 for the US market. Materialise has pioneered numerous groundbreaking medical 3D printing applications. In 2017, it introduced one of the first personalized CMF implant portfolios in the United States. In 2021, its innovative 3D planning and 3D printed instruments played a pivotal role in the world’s first simultaneous double hand and face transplant that was successfully performed at NYU Langone Health in Manhattan, New York.
Subscribe to AM Chronicle Newsletter to stay connected: https://bit.ly/3fBZ1mP
Follow us on LinkedIn: https://bit.ly/3IjhrFq
Visit for more interesting content on additive manufacturing: https://amchronicle.com